Bridgewest merges China-focused BioDuro with Formex in San Diego base

China-focused CRO BioDuro has merged with manufacturing company Formex in the U.S. as part of an apparent reorganization under owner Bridgewest Group with all three companies located in San Diego. BioDuro was sold to CRO PPD in 2012 by Bridgewest CEO and partner Masood Tayebi, who promptly bought it back last year. The combined company will be helmed by Cyrus Mirsaidi. BioDuro has a 100,000-square-foot facility in Beijing, focused on biosimilars, synthetic, medicinal and computational chemistry, and a 92,000-square-foot facility in Shanghai for drug screening, drug metabolism and pharmacokinetic and integrated biology. T. J. Deng will continue as general manager for China. Formex handles active pharmaceutical ingredient (API) formulations and has a turnkey 44,000-square-foot manufacturing facility in San Diego, according to a press release. "Under the terms of the agreement, the combined companies will operate under the corporate structure of BioDuro, headquartered in San Diego, California. The formulation and manufacturing group at Formex will continue to operate in San Diego, as a wholly-owned subsidiary of BioDuro." Release | More from FierceCRO